Showing results (111-120 of 135) with videos related to
Sort By:
Pageof 14
Hepatology (Baltimore, Md.)|January 10, 2013
Hypoxia-mediated sorafenib resistance can be overcome by EF24 through Von Hippel-Lindau tumor suppressor-dependent HIF-1α inhibition in hepatocellular carcinomaYingjian Liang, Tongsen Zheng, Ruipeng Song, et al.Translational Research : the Journal of Laboratory and Clinical Medicine|January 17, 2012
Enhanced induction of heme oxygenase-1 suppresses thrombus formation and affects the protein C system in sepsisDongsheng Fei, Xianglin Meng, Mingran Zhao, et al.Hepatology Communications|November 25, 2024
Von Hippel-Lindau deficiency protects the liver against ischemia/reperfusion injury through the regulation of hypoxia-inducible factor 1α and 2αZihao Li, Bing Yin, Yanan Xu, et al.The FEBS Journal|October 30, 2013
Up-regulation of survivin by AKT and hypoxia-inducible factor 1α contributes to cisplatin resistance in gastric cancerXue-Pu Sun, Xuesong Dong, Lele Lin, et al.Oncogenesis|January 20, 2023
HLTF promotes hepatocellular carcinoma progression by enhancing SRSF1 stability and activating ERK/MAPK pathwayYanan Xu, Shanjia Ke, Shounan Lu, et al.Oncotarget|May 28, 2015
YAP is a critical oncogene in human cholangiocarcinomaTiemin Pei, Yuejin Li, Jiabei Wang, et al.Cancer Science|January 16, 2024
IRG1 restrains M2 macrophage polarization and suppresses intrahepatic cholangiocarcinoma progression via the CCL18/STAT3 pathwayMenghua Zhou, Hongjun Yu, Miaoyu Bai, et al.Scientific Reports|December 4, 2015
A preliminary study of ALPPS procedure in a rat modelHuawen Shi, Guangchao Yang, Tongsen Zheng, et al.Scientific Reports|January 24, 2017
Reduction of hepatic fibrosis by overexpression of von Hippel-Lindau protein in experimental models of chronic liver diseaseJizhou Wang, Zhaoyang Lu, Zhilin Xu, et al.Oncogenesis|May 30, 2020
lncRNA-SOX2OT promotes hepatocellular carcinoma invasion and metastasis through miR-122-5p-mediated activation of PKM2Yingjian Liang, Dandan Zhang, Tongsen Zheng, et al.Pageof 14